MaximBio’s COVID-19 Antigen Home Test Gets Distribution Agreement
The ClearDetect COVID-19 Antigen Home Test (ClearDetect) which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The ClearDetect COVID-19 Antigen Home Test (ClearDetect) which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The new service features proctored telehealth by which a technician observes proper sample collection, confirms identity, and certifies results reporting.
Read MorePosted by Andy Lundin | Jan 27, 2022 | Diagnostic Technologies, Respiratory Disease |
LightDeck Diagnostics received a $2 million contract for the development of a rapid, quantitative, multiplexed test for inflammatory markers.
Read MorePosted by Andy Lundin | Jan 26, 2022 | Fertility Testing |
The new method could significantly improve diagnosis of male infertility, which is more important than ever now that infertility rates are mounting.
Read MorePosted by Andy Lundin | Jan 18, 2022 | Covid 19, Immunoassay Reagents & test Kits |
In-house wet testing with the virus demonstrated that the LumiraDx SARS-CoV-2 Antigen test detects the Omicron variant.
Read More